<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">35661830</PMID><DateCompleted><Year>2022</Year><Month>07</Month><Day>07</Day></DateCompleted><DateRevised><Year>2023</Year><Month>07</Month><Day>03</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1748-7838</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>7</Issue><PubDate><Year>2022</Year><Month>Jul</Month></PubDate></JournalIssue><Title>Cell research</Title><ISOAbbreviation>Cell Res</ISOAbbreviation></Journal><ArticleTitle>Nuclear RIPK1 promotes chromatin remodeling to mediate inflammatory response.</ArticleTitle><Pagination><StartPage>621</StartPage><EndPage>637</EndPage><MedlinePgn>621-637</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41422-022-00673-3</ELocationID><Abstract><AbstractText>RIPK1 is a master regulator of multiple cell death pathways, including apoptosis and necroptosis, and inflammation. Importantly, activation of RIPK1 has also been shown to promote the transcriptional induction of proinflammatory cytokines in cells undergoing necroptosis, in animal models of amyotrophic lateral sclerosis (ALS) and Alzheimer's disease (AD), and in human ALS and AD. Rare human genetic carriers of non-cleavable RIPK1 variants (D324V and D324H) exhibit distinct symptoms of recurrent fevers and increased transcription of proinflammatory cytokines. Multiple RIPK1 inhibitors have been advanced into human clinical trials as new therapeutics for human inflammatory and neurodegenerative diseases, such as ALS and AD. However, it is unclear whether and how RIPK1 kinase activity directly mediates inflammation independent of cell death as the nuclear function of RIPK1 has not yet been explored. Here we show that nuclear RIPK1 is physically associated with the BAF complex. Upon RIPK1 activation, the RIPK1/BAF complex is recruited by specific transcription factors to active enhancers and promoters marked by H3K4me1 and H3K27ac. Activated nuclear RIPK1 mediates the phosphorylation of SMARCC2, a key component of the BAF complex, to promote chromatin remodeling and the transcription of specific proinflammatory genes. Increased nuclear RIPK1 activation and RIPK1/BAF-mediated chromatin-remodeling activity were found in cells expressing non-cleavable RIPK1, and increased enrichment of activated RIPK1 on active enhancers and promoters was found in an animal model and human pathological samples of ALS. Our results suggest that RIPK1 kinase serves as a transcriptional coregulator in nucleus that can transmit extracellular stimuli to the BAF complex to modulate chromatin accessibility and directly regulate the transcription of specific genes involved in mediating inflammatory responses.</AbstractText><CopyrightInformation>&#xa9; 2022. The Author(s) under exclusive licence to Center for Excellence in Molecular Cell Science, CAS.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Wanjin</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA. wanjinli@sioc.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China. wanjinli@sioc.ac.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shan</LastName><ForeName>Bing</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zou</LastName><ForeName>Chengyu</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Huibing</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Meng-Meng</ForeName><Initials>MM</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Naito</LastName><ForeName>Masanori Gomi</ForeName><Initials>MG</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Xu</LastName><ForeName>Daichao</ForeName><Initials>D</Initials><Identifier Source="ORCID">0000-0002-3286-4968</Identifier><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Manuel</LastName><ForeName>Vica Jean</ForeName><Initials>VJ</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mifflin</LastName><ForeName>Lauren</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0003-1607-5851</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hou</LastName><ForeName>Zhaodong</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ravits</LastName><ForeName>John</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>ALS Translational Research Program, Department of Neurosciences, University of California, San Diego, La Jolla, CA, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuan</LastName><ForeName>Junying</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-2405-6036</Identifier><AffiliationInfo><Affiliation>Department of Cell Biology, Harvard Medical School, Boston, MA, USA. junying_yuan@sioc.ac.cn.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Interdisciplinary Research Center on Biology and Chemistry, Shanghai Institute of Organic Chemistry, Chinese Academy of Sciences, Shanghai, China. junying_yuan@sioc.ac.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>06</Month><Day>03</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Res</MedlineTA><NlmUniqueID>9425763</NlmUniqueID><ISSNLinking>1001-0602</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002843">Chromatin</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016207">Cytokines</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 2.7.11.1</RegistryNumber><NameOfSubstance UI="D053422">Receptor-Interacting Protein Serine-Threonine Kinases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><CommentsCorrectionsList><CommentsCorrections RefType="CommentIn"><RefSource>Cell Res. 2022 Aug;32(8):709-710</RefSource><PMID Version="1">35787662</PMID></CommentsCorrections></CommentsCorrectionsList><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D017209" MajorTopicYN="N">Apoptosis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002843" MajorTopicYN="N">Chromatin</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D042002" MajorTopicYN="N">Chromatin Assembly and Disassembly</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016207" MajorTopicYN="N">Cytokines</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053422" MajorTopicYN="N">Receptor-Interacting Protein Serine-Threonine Kinases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>J.Y. is a consultant for Sanofi. The other authors declare that they have no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>5</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2022</Year><Month>5</Month><Day>10</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>6</Month><Day>7</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>7</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>6</Month><Day>6</Day><Hour>12</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35661830</ArticleId><ArticleId IdType="pmc">PMC9253060</ArticleId><ArticleId IdType="doi">10.1038/s41422-022-00673-3</ArticleId><ArticleId IdType="pii">10.1038/s41422-022-00673-3</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Mifflin L, Ofengeim D, Yuan J. Receptor-interacting protein kinase 1 (RIPK1) as a therapeutic target. Nat. Rev. Drug Discov. 2020;19:553&#x2013;571. doi: 10.1038/s41573-020-0071-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41573-020-0071-y</ArticleId><ArticleId IdType="pmc">PMC7362612</ArticleId><ArticleId IdType="pubmed">32669658</ArticleId></ArticleIdList></Reference><Reference><Citation>Ito Y, et al. RIPK1 mediates axonal degeneration by promoting inflammation and necroptosis in ALS. Science. 2016;353:603&#x2013;608. doi: 10.1126/science.aaf6803.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf6803</ArticleId><ArticleId IdType="pmc">PMC5444917</ArticleId><ArticleId IdType="pubmed">27493188</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofengeim D, et al. RIPK1 mediates a disease-associated microglial response in Alzheimer&#x2019;s disease. Proc. Natl. Acad. Sci. USA. 2017;114:E8788&#x2013;E8797. doi: 10.1073/pnas.1714175114.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1714175114</ArticleId><ArticleId IdType="pmc">PMC5642727</ArticleId><ArticleId IdType="pubmed">28904096</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu K, et al. Necroptosis promotes cell-autonomous activation of proinflammatory cytokine gene expression. Cell Death Dis. 2018;9:500. doi: 10.1038/s41419-018-0524-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-018-0524-y</ArticleId><ArticleId IdType="pmc">PMC5923285</ArticleId><ArticleId IdType="pubmed">29703889</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalaoui N, et al. Mutations that prevent caspase cleavage of RIPK1 cause autoinflammatory disease. Nature. 2020;577:103&#x2013;108. doi: 10.1038/s41586-019-1828-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1828-5</ArticleId><ArticleId IdType="pmc">PMC6930849</ArticleId><ArticleId IdType="pubmed">31827281</ArticleId></ArticleIdList></Reference><Reference><Citation>Tao P, et al. A dominant autoinflammatory disease caused by non-cleavable variants of RIPK1. Nature. 2020;577:109&#x2013;114. doi: 10.1038/s41586-019-1830-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1830-y</ArticleId><ArticleId IdType="pubmed">31827280</ArticleId></ArticleIdList></Reference><Reference><Citation>Hargreaves DC, Crabtree GR. ATP-dependent chromatin remodeling: genetics, genomics and mechanisms. Cell Res. 2011;21:396&#x2013;420. doi: 10.1038/cr.2011.32.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cr.2011.32</ArticleId><ArticleId IdType="pmc">PMC3110148</ArticleId><ArticleId IdType="pubmed">21358755</ArticleId></ArticleIdList></Reference><Reference><Citation>Sokpor G, Xie Y, Rosenbusch J, Tuoc T. Chromatin remodeling BAF (SWI/SNF) complexes in neural development and disorders. Front. Mol. Neurosci. 2017;10:243. doi: 10.3389/fnmol.2017.00243.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2017.00243</ArticleId><ArticleId IdType="pmc">PMC5540894</ArticleId><ArticleId IdType="pubmed">28824374</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho L, Crabtree GR. Chromatin remodelling during development. Nature. 2010;463:474&#x2013;484. doi: 10.1038/nature08911.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature08911</ArticleId><ArticleId IdType="pmc">PMC3060774</ArticleId><ArticleId IdType="pubmed">20110991</ArticleId></ArticleIdList></Reference><Reference><Citation>Heintzman ND, et al. Distinct and predictive chromatin signatures of transcriptional promoters and enhancers in the human genome. Nat. Genet. 2007;39:311&#x2013;318. doi: 10.1038/ng1966.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ng1966</ArticleId><ArticleId IdType="pubmed">17277777</ArticleId></ArticleIdList></Reference><Reference><Citation>Creyghton MP, et al. Histone H3K27ac separates active from poised enhancers and predicts developmental state. Proc. Natl. Acad. Sci. USA. 2010;107:21931&#x2013;21936. doi: 10.1073/pnas.1016071107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1016071107</ArticleId><ArticleId IdType="pmc">PMC3003124</ArticleId><ArticleId IdType="pubmed">21106759</ArticleId></ArticleIdList></Reference><Reference><Citation>Ofengeim D, et al. Activation of necroptosis in multiple sclerosis. Cell Rep. 2015;10:1836&#x2013;1849. doi: 10.1016/j.celrep.2015.02.051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.02.051</ArticleId><ArticleId IdType="pmc">PMC4494996</ArticleId><ArticleId IdType="pubmed">25801023</ArticleId></ArticleIdList></Reference><Reference><Citation>Li X, et al. Ubiquitination of RIPK1 regulates its activation mediated by TNFR1 and TLRs signaling in distinct manners. Nat. Commun. 2020;11:6364. doi: 10.1038/s41467-020-19935-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-020-19935-y</ArticleId><ArticleId IdType="pmc">PMC7733462</ArticleId><ArticleId IdType="pubmed">33311474</ArticleId></ArticleIdList></Reference><Reference><Citation>Degterev A, et al. Identification of RIP1 kinase as a specific cellular target of necrostatins. Nat. Chem. Biol. 2008;4:313&#x2013;321. doi: 10.1038/nchembio.83.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nchembio.83</ArticleId><ArticleId IdType="pmc">PMC5434866</ArticleId><ArticleId IdType="pubmed">18408713</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallach D, Kang TB, Dillon CP, Green DR. Programmed necrosis in inflammation: Toward identification of the effector molecules. Science. 2016;352:aaf2154. doi: 10.1126/science.aaf2154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaf2154</ArticleId><ArticleId IdType="pubmed">27034377</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Dowling JP, Zhang J. RIPK1 can mediate apoptosis in addition to necroptosis during embryonic development. Cell Death Dis. 2019;10:245. doi: 10.1038/s41419-019-1490-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41419-019-1490-8</ArticleId><ArticleId IdType="pmc">PMC6416317</ArticleId><ArticleId IdType="pubmed">30867408</ArticleId></ArticleIdList></Reference><Reference><Citation>Newton K, et al. Cleavage of RIPK1 by caspase-8 is crucial for limiting apoptosis and necroptosis. Nature. 2019;574:428&#x2013;431. doi: 10.1038/s41586-019-1548-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-019-1548-x</ArticleId><ArticleId IdType="pubmed">31511692</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafov A, et al. BRAF and AXL oncogenes drive RIPK3 expression loss in cancer. PLoS Biol. 2018;16:e2005756. doi: 10.1371/journal.pbio.2005756.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2005756</ArticleId><ArticleId IdType="pmc">PMC6114281</ArticleId><ArticleId IdType="pubmed">30157175</ArticleId></ArticleIdList></Reference><Reference><Citation>Najafov A, Chen H, Yuan J. Necroptosis and cancer. Trends Cancer. 2017;3:294&#x2013;301. doi: 10.1016/j.trecan.2017.03.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.trecan.2017.03.002</ArticleId><ArticleId IdType="pmc">PMC5402749</ArticleId><ArticleId IdType="pubmed">28451648</ArticleId></ArticleIdList></Reference><Reference><Citation>Local A, et al. Identification of H3K4me1-associated proteins at mammalian enhancers. Nat. Genet. 2018;50:73&#x2013;82. doi: 10.1038/s41588-017-0015-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-017-0015-6</ArticleId><ArticleId IdType="pmc">PMC6007000</ArticleId><ArticleId IdType="pubmed">29255264</ArticleId></ArticleIdList></Reference><Reference><Citation>Rada-Iglesias A, et al. A unique chromatin signature uncovers early developmental enhancers in humans. Nature. 2011;470:279&#x2013;283. doi: 10.1038/nature09692.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature09692</ArticleId><ArticleId IdType="pmc">PMC4445674</ArticleId><ArticleId IdType="pubmed">21160473</ArticleId></ArticleIdList></Reference><Reference><Citation>Henikoff S, Henikoff JG, Kaya-Okur HS, Ahmad K. Efficient chromatin accessibility mapping in situ by nucleosome-tethered tagmentation. Elife. 2020;9:e63274. doi: 10.7554/eLife.63274.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.63274</ArticleId><ArticleId IdType="pmc">PMC7721439</ArticleId><ArticleId IdType="pubmed">33191916</ArticleId></ArticleIdList></Reference><Reference><Citation>Kaya-Okur HS, et al. CUT&amp;Tag for efficient epigenomic profiling of small samples and single cells. Nat. Commun. 2019;10:1930. doi: 10.1038/s41467-019-09982-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09982-5</ArticleId><ArticleId IdType="pmc">PMC6488672</ArticleId><ArticleId IdType="pubmed">31036827</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou Y, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat. Commun. 2019;10:1523. doi: 10.1038/s41467-019-09234-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09234-6</ArticleId><ArticleId IdType="pmc">PMC6447622</ArticleId><ArticleId IdType="pubmed">30944313</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu D, et al. TBK1 suppresses RIPK1-driven apoptosis and inflammation during development and in aging. Cell. 2018;174:1477&#x2013;1491.e19. doi: 10.1016/j.cell.2018.07.041.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2018.07.041</ArticleId><ArticleId IdType="pmc">PMC6128749</ArticleId><ArticleId IdType="pubmed">30146158</ArticleId></ArticleIdList></Reference><Reference><Citation>Song F, Chiang P, Wang J, Ravits J, Loeb JA. Aberrant neuregulin 1 signaling in amyotrophic lateral sclerosis. J. Neuropathol. Exp. Neurol. 2012;71:104&#x2013;115. doi: 10.1097/NEN.0b013e3182423c43.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e3182423c43</ArticleId><ArticleId IdType="pmc">PMC3270561</ArticleId><ArticleId IdType="pubmed">22249457</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng D, et al. The genome-wide transcriptional regulatory landscape of ecdysone in the silkworm. Epigenet. Chromatin. 2018;11:48. doi: 10.1186/s13072-018-0216-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-018-0216-y</ArticleId><ArticleId IdType="pmc">PMC6109983</ArticleId><ArticleId IdType="pubmed">30149809</ArticleId></ArticleIdList></Reference><Reference><Citation>Herrera-Uribe J, et al. Changes in H3K27ac at gene regulatory regions in porcine alveolar macrophages following LPS or polyIC exposure. Front. Genet. 2020;11:817. doi: 10.3389/fgene.2020.00817.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fgene.2020.00817</ArticleId><ArticleId IdType="pmc">PMC7468443</ArticleId><ArticleId IdType="pubmed">32973863</ArticleId></ArticleIdList></Reference><Reference><Citation>Chiu IM, et al. A neurodegeneration-specific gene-expression signature of acutely isolated microglia from an amyotrophic lateral sclerosis mouse model. Cell Rep. 2013;4:385&#x2013;401. doi: 10.1016/j.celrep.2013.06.018.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2013.06.018</ArticleId><ArticleId IdType="pmc">PMC4272581</ArticleId><ArticleId IdType="pubmed">23850290</ArticleId></ArticleIdList></Reference><Reference><Citation>Iurlaro M, et al. Mammalian SWI/SNF continuously restores local accessibility to chromatin. Nat. Genet. 2021;53:279&#x2013;287. doi: 10.1038/s41588-020-00768-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41588-020-00768-w</ArticleId><ArticleId IdType="pubmed">33558757</ArticleId></ArticleIdList></Reference><Reference><Citation>Monaco C, Nanchahal J, Taylor P, Feldmann M. Anti-TNF therapy: past, present and future. Int. Immunol. 2015;27:55&#x2013;62. doi: 10.1093/intimm/dxu102.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxu102</ArticleId><ArticleId IdType="pmc">PMC4279876</ArticleId><ArticleId IdType="pubmed">25411043</ArticleId></ArticleIdList></Reference><Reference><Citation>Bao X, et al. A novel ATAC-seq approach reveals lineage-specific reinforcement of the open chromatin landscape via cooperation between BAF and p63. Genome Biol. 2015;16:284. doi: 10.1186/s13059-015-0840-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-015-0840-9</ArticleId><ArticleId IdType="pmc">PMC4699366</ArticleId><ArticleId IdType="pubmed">26683334</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwon H, Imbalzano AN, Khavari PA, Kingston RE, Green MR. Nucleosome disruption and enhancement of activator binding by a human SW1/SNF complex. Nature. 1994;370:477&#x2013;481. doi: 10.1038/370477a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/370477a0</ArticleId><ArticleId IdType="pubmed">8047169</ArticleId></ArticleIdList></Reference><Reference><Citation>Ochoa D, et al. The functional landscape of the human phosphoproteome. Nat. Biotechnol. 2020;38:365&#x2013;373. doi: 10.1038/s41587-019-0344-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41587-019-0344-3</ArticleId><ArticleId IdType="pmc">PMC7100915</ArticleId><ArticleId IdType="pubmed">31819260</ArticleId></ArticleIdList></Reference><Reference><Citation>Chesi A, et al. Exome sequencing to identify de novo mutations in sporadic ALS trios. Nat. Neurosci. 2013;16:851&#x2013;855. doi: 10.1038/nn.3412.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3412</ArticleId><ArticleId IdType="pmc">PMC3709464</ArticleId><ArticleId IdType="pubmed">23708140</ArticleId></ArticleIdList></Reference><Reference><Citation>Machol K, et al. Expanding the spectrum of BAF-related disorders: de novo variants in SMARCC2 cause a syndrome with intellectual disability and developmental delay. Am. J. Hum. Genet. 2019;104:164&#x2013;178. doi: 10.1016/j.ajhg.2018.11.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2018.11.007</ArticleId><ArticleId IdType="pmc">PMC6323608</ArticleId><ArticleId IdType="pubmed">30580808</ArticleId></ArticleIdList></Reference><Reference><Citation>Huttlin EL, et al. A tissue-specific atlas of mouse protein phosphorylation and expression. Cell. 2010;143:1174&#x2013;1189. doi: 10.1016/j.cell.2010.12.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2010.12.001</ArticleId><ArticleId IdType="pmc">PMC3035969</ArticleId><ArticleId IdType="pubmed">21183079</ArticleId></ArticleIdList></Reference><Reference><Citation>Tak PP, Firestein GS. NF-kappaB: a key role in inflammatory diseases. J. Clin. Invest. 2001;107:7&#x2013;11. doi: 10.1172/JCI11830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI11830</ArticleId><ArticleId IdType="pmc">PMC198552</ArticleId><ArticleId IdType="pubmed">11134171</ArticleId></ArticleIdList></Reference><Reference><Citation>Fiuza C, et al. Inflammation-promoting activity of HMGB1 on human microvascular endothelial cells. Blood. 2003;101:2652&#x2013;2660. doi: 10.1182/blood-2002-05-1300.</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood-2002-05-1300</ArticleId><ArticleId IdType="pubmed">12456506</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown JD, et al. NF-kappaB directs dynamic super enhancer formation in inflammation and atherogenesis. Mol. Cell. 2014;56:219&#x2013;231. doi: 10.1016/j.molcel.2014.08.024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2014.08.024</ArticleId><ArticleId IdType="pmc">PMC4224636</ArticleId><ArticleId IdType="pubmed">25263595</ArticleId></ArticleIdList></Reference><Reference><Citation>Fontana MF, et al. JUNB is a key transcriptional modulator of macrophage activation. J. Immunol. 2015;194:177&#x2013;186. doi: 10.4049/jimmunol.1401595.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1401595</ArticleId><ArticleId IdType="pmc">PMC4431620</ArticleId><ArticleId IdType="pubmed">25472994</ArticleId></ArticleIdList></Reference><Reference><Citation>Schonthaler HB, Guinea-Viniegra J, Wagner EF. Targeting inflammation by modulating the Jun/AP-1 pathway. Ann. Rheum. Dis. 2011;70:i109&#x2013;i112. doi: 10.1136/ard.2010.140533.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/ard.2010.140533</ArticleId><ArticleId IdType="pubmed">21339212</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu Z, et al. Sp1 is up-regulated in cellular and transgenic models of Huntington disease, and its reduction is neuroprotective. J. Biol. Chem. 2006;281:16672&#x2013;16680. doi: 10.1074/jbc.M511648200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M511648200</ArticleId><ArticleId IdType="pubmed">16595660</ArticleId></ArticleIdList></Reference><Reference><Citation>Ravache M, Weber C, Merienne K, Trottier Y. Transcriptional activation of REST by Sp1 in Huntington&#x2019;s disease models. PLoS One. 2010;5:e14311. doi: 10.1371/journal.pone.0014311.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0014311</ArticleId><ArticleId IdType="pmc">PMC3001865</ArticleId><ArticleId IdType="pubmed">21179468</ArticleId></ArticleIdList></Reference><Reference><Citation>Swarup V, et al. Deregulation of TDP-43 in amyotrophic lateral sclerosis triggers nuclear factor kappaB-mediated pathogenic pathways. J. Exp. Med. 2011;208:2429&#x2013;2447. doi: 10.1084/jem.20111313.</Citation><ArticleIdList><ArticleId IdType="doi">10.1084/jem.20111313</ArticleId><ArticleId IdType="pmc">PMC3256969</ArticleId><ArticleId IdType="pubmed">22084410</ArticleId></ArticleIdList></Reference><Reference><Citation>Frakes AE, et al. Microglia induce motor neuron death via the classical NF-kappaB pathway in amyotrophic lateral sclerosis. Neuron. 2014;81:1009&#x2013;1023. doi: 10.1016/j.neuron.2014.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.01.013</ArticleId><ArticleId IdType="pmc">PMC3978641</ArticleId><ArticleId IdType="pubmed">24607225</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikiz B, et al. The regulatory machinery of neurodegeneration in in vitro models of amyotrophic lateral sclerosis. Cell Rep. 2015;12:335&#x2013;345. doi: 10.1016/j.celrep.2015.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2015.06.019</ArticleId><ArticleId IdType="pmc">PMC4646662</ArticleId><ArticleId IdType="pubmed">26146077</ArticleId></ArticleIdList></Reference><Reference><Citation>Geng J, et al. Regulation of RIPK1 activation by TAK1-mediated phosphorylation dictates apoptosis and necroptosis. Nat. Commun. 2017;8:359. doi: 10.1038/s41467-017-00406-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-017-00406-w</ArticleId><ArticleId IdType="pmc">PMC5572456</ArticleId><ArticleId IdType="pubmed">28842570</ArticleId></ArticleIdList></Reference><Reference><Citation>Dondelinger Y, et al. Serine 25 phosphorylation inhibits RIPK1 kinase-dependent cell death in models of infection and inflammation. Nat. Commun. 2019;10:1729. doi: 10.1038/s41467-019-09690-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-09690-0</ArticleId><ArticleId IdType="pmc">PMC6465317</ArticleId><ArticleId IdType="pubmed">30988283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ishii KJ, et al. TANK-binding kinase-1 delineates innate and adaptive immune responses to DNA vaccines. Nature. 2008;451:725&#x2013;729. doi: 10.1038/nature06537.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature06537</ArticleId><ArticleId IdType="pubmed">18256672</ArticleId></ArticleIdList></Reference><Reference><Citation>Sato S, et al. Essential function for the kinase TAK1 in innate and adaptive immune responses. Nat. Immunol. 2005;6:1087&#x2013;1095. doi: 10.1038/ni1255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni1255</ArticleId><ArticleId IdType="pubmed">16186825</ArticleId></ArticleIdList></Reference><Reference><Citation>Gagnon KT, Li L, Janowski BA, Corey DR. Analysis of nuclear RNA interference in human cells by subcellular fractionation and Argonaute loading. Nat. Protoc. 2014;9:2045&#x2013;2060. doi: 10.1038/nprot.2014.135.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2014.135</ArticleId><ArticleId IdType="pmc">PMC4251768</ArticleId><ArticleId IdType="pubmed">25079428</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J, Mann M. MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification. Nat. Biotechnol. 2008;26:1367&#x2013;1372. doi: 10.1038/nbt.1511.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1511</ArticleId><ArticleId IdType="pubmed">19029910</ArticleId></ArticleIdList></Reference><Reference><Citation>Si W, et al. Dysfunction of the reciprocal feedback loop between GATA3- and ZEB2-nucleated repression programs contributes to breast cancer metastasis. Cancer Cell. 2015;27:822&#x2013;836. doi: 10.1016/j.ccell.2015.04.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccell.2015.04.011</ArticleId><ArticleId IdType="pubmed">26028330</ArticleId></ArticleIdList></Reference><Reference><Citation>Li W, et al. The FOXN3-NEAT1-SIN3A repressor complex promotes progression of hormonally responsive breast cancer. J. Clin. Invest. 2017;127:3421&#x2013;3440. doi: 10.1172/JCI94233.</Citation><ArticleIdList><ArticleId IdType="doi">10.1172/JCI94233</ArticleId><ArticleId IdType="pmc">PMC5669564</ArticleId><ArticleId IdType="pubmed">28805661</ArticleId></ArticleIdList></Reference><Reference><Citation>Iwase S, et al. The X-linked mental retardation gene SMCX/JARID1C defines a family of histone H3 lysine 4 demethylases. Cell. 2007;128:1077&#x2013;1088. doi: 10.1016/j.cell.2007.02.017.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2007.02.017</ArticleId><ArticleId IdType="pubmed">17320160</ArticleId></ArticleIdList></Reference><Reference><Citation>Langmead B, Salzberg SL. Fast gapped-read alignment with Bowtie 2. Nat Methods. 2012;9:357&#x2013;359. doi: 10.1038/nmeth.1923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.1923</ArticleId><ArticleId IdType="pmc">PMC3322381</ArticleId><ArticleId IdType="pubmed">22388286</ArticleId></ArticleIdList></Reference><Reference><Citation>Meers MP, Tenenbaum D, Henikoff S. Peak calling by Sparse Enrichment Analysis for CUT&amp;RUN chromatin profiling. Epigenet. Chromatin. 2019;12:42. doi: 10.1186/s13072-019-0287-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13072-019-0287-4</ArticleId><ArticleId IdType="pmc">PMC6624997</ArticleId><ArticleId IdType="pubmed">31300027</ArticleId></ArticleIdList></Reference><Reference><Citation>Quinlan AR, Hall IM. BEDTools: a flexible suite of utilities for comparing genomic features. Bioinformatics. 2010;26:841&#x2013;842. doi: 10.1093/bioinformatics/btq033.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btq033</ArticleId><ArticleId IdType="pmc">PMC2832824</ArticleId><ArticleId IdType="pubmed">20110278</ArticleId></ArticleIdList></Reference><Reference><Citation>Heinz S, et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell. 2010;38:576&#x2013;589. doi: 10.1016/j.molcel.2010.05.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.molcel.2010.05.004</ArticleId><ArticleId IdType="pmc">PMC2898526</ArticleId><ArticleId IdType="pubmed">20513432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ramirez F, et al. deepTools2: a next generation web server for deep-sequencing data analysis. Nucleic Acids Res. 2016;44:W160&#x2013;W165. doi: 10.1093/nar/gkw257.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkw257</ArticleId><ArticleId IdType="pmc">PMC4987876</ArticleId><ArticleId IdType="pubmed">27079975</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson JT, et al. Integrative genomics viewer. Nat. Biotechnol. 2011;29:24&#x2013;26. doi: 10.1038/nbt.1754.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nbt.1754</ArticleId><ArticleId IdType="pmc">PMC3346182</ArticleId><ArticleId IdType="pubmed">21221095</ArticleId></ArticleIdList></Reference><Reference><Citation>Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and bias-aware quantification of transcript expression. Nat. Methods. 2017;14:417&#x2013;419. doi: 10.1038/nmeth.4197.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4197</ArticleId><ArticleId IdType="pmc">PMC5600148</ArticleId><ArticleId IdType="pubmed">28263959</ArticleId></ArticleIdList></Reference><Reference><Citation>Love MI, Huber W, Anders S. Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550. doi: 10.1186/s13059-014-0550-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13059-014-0550-8</ArticleId><ArticleId IdType="pmc">PMC4302049</ArticleId><ArticleId IdType="pubmed">25516281</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenrostro JD, Giresi PG, Zaba LC, Chang HY, Greenleaf WJ. Transposition of native chromatin for fast and sensitive epigenomic profiling of open chromatin, DNA-binding proteins and nucleosome position. Nat. Methods. 2013;10:1213&#x2013;1218. doi: 10.1038/nmeth.2688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.2688</ArticleId><ArticleId IdType="pmc">PMC3959825</ArticleId><ArticleId IdType="pubmed">24097267</ArticleId></ArticleIdList></Reference><Reference><Citation>Buenrostro JD, Wu B, Chang HY, Greenleaf WJ. ATAC-seq: a method for assaying chromatin accessibility genome-wide. Curr. Protoc. Mol. Biol. 2015;109:21.29.1&#x2013;21.29.9. doi: 10.1002/0471142727.mb2129s109.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471142727.mb2129s109</ArticleId><ArticleId IdType="pmc">PMC4374986</ArticleId><ArticleId IdType="pubmed">25559105</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, et al. Corepressor protein CDYL functions as a molecular bridge between polycomb repressor complex 2 and repressive chromatin mark trimethylated histone lysine 27. J. Biol. Chem. 2011;286:42414&#x2013;42425. doi: 10.1074/jbc.M111.271064.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M111.271064</ArticleId><ArticleId IdType="pmc">PMC3234934</ArticleId><ArticleId IdType="pubmed">22009739</ArticleId></ArticleIdList></Reference><Reference><Citation>Nott A, et al. Brain cell type-specific enhancer-promoter interactome maps and disease-risk association. Science. 2019;366:1134&#x2013;1139. doi: 10.1126/science.aay0793.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aay0793</ArticleId><ArticleId IdType="pmc">PMC7028213</ArticleId><ArticleId IdType="pubmed">31727856</ArticleId></ArticleIdList></Reference><Reference><Citation>McQuin C, et al. CellProfiler 3.0: Next-generation image processing for biology. PLoS Biol. 2018;16:e2005970. doi: 10.1371/journal.pbio.2005970.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pbio.2005970</ArticleId><ArticleId IdType="pmc">PMC6029841</ArticleId><ArticleId IdType="pubmed">29969450</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>